Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
4.730
-0.160 (-3.27%)
Feb 21, 2025, 4:00 PM EST - Market closed
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $14.00K in the quarter ending September 30, 2024, a decrease of -51.72%. This brings the company's revenue in the last twelve months to $3.16M, up 2,454.55% year-over-year. In the year 2023, Serina Therapeutics had annual revenue of $3.15M with 433.14% growth.
Revenue (ttm)
$3.16M
Revenue Growth
+2,454.55%
P/S Ratio
8.59
Revenue / Employee
$287,045
Employees
11
Market Cap
44.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.15M | 2.56M | 433.14% |
Dec 31, 2022 | 591.50K | -2.87M | -82.93% |
Dec 31, 2021 | 3.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 10 days ago - Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewsWire
- 19 days ago - Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - GlobeNewsWire
- 2 months ago - Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - GlobeNewsWire
- 2 months ago - Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewsWire
- 2 months ago - Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 3 months ago - Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire